BioTime News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

16.06.21	Lineage Cell Therapeutics Announces Kevin L. Cook to Join as Chief Financial Officer (Businesswire)
15.06.21	Lineage Cell Therapeutics to Present at Raymond James 2021 Human Health Innovation Conference on June 22, 2021 (Businesswire)
09.06.21	Lineage Cell Therapeutics Set to Join Russell 3000® Index and Russell Microcap® Index (Businesswire)
01.06.21	Lineage Cell Therapeutics Reports Additional Cases of Retinal Tissue Restoration in Dry AMD Patients Treated With OpRegen® RPE Cells (Businesswire)
13.05.21	Lineage Reports First Quarter 2021 Financial Results and Highlights Significant Progress With All Three Clinical Programs (Businesswire)
05.05.21	Lineage Announces Appointment of Anula Jayasuriya, M.D., PH.D., M.B.A., to Board of Directors (Businesswire)
04.05.21	Lineage Cell Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on May 13, 2021 (Businesswire)
03.05.21	OpRegen® Clinical Data Continues to Demonstrate Improvements in Patients With Dry AMD With Geographic Atrophy (Businesswire)
26.04.21	Lineage to Present at the B. Riley Securities’ Neuroscience Conference on April 28, 2021 (Businesswire)
22.04.21	Lineage Announces Appointment of Dr. Dipti Amin to Its Board of Directors (Businesswire)
20.04.21	Lineage Announces Worldwide License Agreement With Immunomic Therapeutics for an Allogeneic Cell-Based Cancer Immunotherapy Based on Its VAC Platform (Businesswire)
12.04.21	OpRegen® Data Update to Be Featured at 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Presentation by Christopher D. Riemann, MD (Businesswire)
29.03.21	Lineage Cell Therapeutics Announces Vitelliform Maculopathy Patient Treated With OpRegen® Under Named Patient Compassionate Use (Businesswire)
23.03.21	Lineage Cell Therapeutics Presents Additional Interim Data on OpRegen® for Dry AMD With Geographic Atrophy (Businesswire)
17.03.21	Lineage to Present at the Benzinga Global Biotech Small Cap Conference on March 24, 2021 (Businesswire)
11.03.21	Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update (Businesswire)
09.03.21	Ausblick: BioTime legt Zahlen zum jüngsten Quartal vor (finanzen.net)
08.03.21	Lineage Cell Therapeutics Raises $35.9 Million From Sales of Marketable Securities Holdings and an At-the-Market Equity Offering (Businesswire)
01.03.21	Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Business Update on March 11, 2021 (Businesswire)
23.02.21	Lineage to Present at the Raymond James 42nd Annual Institutional Investors Conference on March 1, 2021 and the H.C. Wainwright Global Life Sciences Conference on March 9, 2021 (Businesswire)
16.02.21	Lineage to Host Virtual OPC1 Investor & Analyst Day on February 22, 2021 (Businesswire)
08.02.21	Lineage Enters Into Exclusive Agreement with Neurgain Technologies to Evaluate Novel Delivery System for OPC1 to Treat Spinal Cord Injury (Businesswire)
21.01.21	Lineage Posts Series of Webinars Highlighting Recent Progress With its Three Clinical-Stage Allogeneic Cell Transplant Programs (Businesswire)
21.01.21	PFE/BNTX Covid Jab Neutralizes UK Strain, Pura Vida Ups Stake In OCX, Woodcock Is Interim FDA Chief (RTTNews)
20.01.21	Lineage Cell Therapeutics Announces Change to Executive Team (Businesswire)
20.01.21	Pre-market Movers In Healthcare Sector: LCTX, DARE, SRNE, NOVN, HSTO… (RTTNews)
28.12.20	Lineage Cell Therapeutics Provides End of Year Shareholder Letter (Businesswire)
09.12.20	Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020 (Businesswire)
08.12.20	Lineage Cell Therapeutics Provides Update on OPC1 Cell Therapy Program for the Treatment of Spinal Cord Injury (Businesswire)
16.11.20	Lineage Cell Therapeutics Presents New OpRegen® Data for Dry AMD With GA at 2020 American Academy of Ophthalmology Annual Meeting (Businesswire)
15.11.20	Week Ahead In Pharma: FDA Decisions, Data Readouts (ADMP, EIGR, KZIA, AVRO…) (RTTNews)
13.11.20	Lineage Cell Therapeutics Proudly Supports Patients’ Access to Innovative Cell Therapy Treatments and Research Through Passage of Proposition 14 (Businesswire)
11.11.20	Lineage Cell Therapeutics Completes Patient Enrollment in Phase 1/2a Clinical Study of OpRegen® Cell Therapy for the Treatment of Dry Age-related Macular Degeneration (Businesswire)
04.11.20	Lineage Cell Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update (Businesswire)
03.11.20	Ausblick: BioTime stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net)
02.11.20	Lineage Cell Therapeutics to Host Expert Call Following OpRegen® Data Update at 2020 American Academy of Ophthalmology Meeting (Businesswire)
28.10.20	Lineage Cell Therapeutics to Report Third Quarter 2020 Financial Results and Provide Business Update on November 4, 2020 (Businesswire)
15.10.20	OpRegen Data Update to Be Featured in Presentation by Christopher D. Riemann, MD at 2020 American Academy of Ophthalmology Meeting (Businesswire)
13.10.20	Lineage Cell Therapeutics and Cancer Research UK Announce Encouraging Preliminary Phase 1 Study Results With VAC2 for the Treatment of Non-small Cell Lung Cancer (Businesswire)
17.09.20	Lineage Cell Therapeutics to Present at FORCE Wealth Virtual Fireside Chat on September 23, 2020 (Businesswire)
10.09.20	Lineage Cell Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020 and at Cantor Virtual Global Healthcare Conference on September 17, 2020 (Businesswire)
08.09.20	Lineage Cell Therapeutics Awarded Grant From Israel Innovation Authority for Development of a Bio-Retinal Patch for Treatment of Retinal Diseases in Partnership With Precise Bio (Businesswire)
31.08.20	Lineage Cell Therapeutics Receives $24.6 Million Payment From Juvenescence Ltd. (Businesswire)
25.08.20	Lineage Cell Therapeutics to Present at LD Micro 500 Investor Conference and Solebury Trout Zoomside Chat on September 1, 2020 (Businesswire)
06.08.20	Lineage Cell Therapeutics Reports Second Quarter 2020 Financial Results and Provides Update on All Clinical Programs (Businesswire)
05.08.20	Ausblick: BioTime informiert über die jüngsten Quartalsergebnisse (finanzen.net)
30.07.20	Lineage Cell Therapeutics to Report Second Quarter 2020 Financial Results and Provide Business Update on August 6, 2020 (Businesswire)
06.07.20	Lineage Cell Therapeutics Announces Extension of OpRegen® Development Grant From Israel Innovation Authority (Businesswire)
25.06.20	Lineage Cell Therapeutics Provides Update on OPC1 Cell Therapy Program for Spinal Cord Injury (Businesswire)
24.06.20	Lineage Cell Therapeutics to Present OpRegen® Data at International Society for Stem Cell Research (ISSCR) 2020 Virtual Annual Meeting (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’299.00	2.40 %	K V
Holcim	89.04	1.09 %	K V
Roche Hldg G	266.90	0.95 %	K V
ABB	49.88	0.81 %	K V
Novartis	90.96	0.63 %	K V
Givaudan	3’882.00	-0.54 %	K V
Zurich Insur Gr	547.20	-0.83 %	K V
Alcon	76.34	-1.14 %	K V
Logitech Intl	78.74	-1.43 %	K V
Geberit	505.80	-1.52 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu BioTime Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten